hey pumpers, there is NO new set of data due in December...they are going to present Eplipsy preclinical data, which they already published earlier this year. There is nothing new happening here. Not sure what folks are expecting in December.
I would really question the CEO here...why did he work his news release so that it appears that FDA approved phase 2/3 ?? I think there is bit of pumping by CEO when he saw the stock tank so much.
go to SA and read Dr. Kline response to Kanti article.
The drug is no better than DPZ....That is the bottom line.
They are doing a very small selective patient group, on and off treatment for 32 days, maybe included some high doses of coffee in there (who knows?). Just to get on NAZ and pump up the shares. This is some serious pump and dump guys. Go read the comments from PRAN ph 2 from the same doctor in Austrialia...SAYS THE SAME THING ABOUT PRAN !!! Miracle drug....
Be very careful.
wow apple9999 how much money do you want in this POS ??? WHAT A PUMPER ! Having PHDs does not mean the drug works !!! Keep praying for a partnership.
TOTALLY agree. It was misleading news...FDA did not give them guidance for 2/3....it as rehashed PR.
 They will not start phase 2/3 till they get more 12 month data from 2a. They made that clear. So don't expect any news of enrollment for 2/3 till mid 2016 MINIMUM.
 There is going to be NO partnership, despite the hype of the pumpers. No partner is going to put money in a company with only phase 2a.
 Dilution is coming that is for sure. Either thru stock dilution or selling to Lincoln.
 Unfortunately AF is right.....Japanese company already did sigma -1 AZ, and it failed. Pumpers are saying chemical composition is different, but this puts AVXL at VERY HIGH RISK.
 The company is putting positive spin on interim results...but it is such small N, off and on, this is really bad. Something is not right. If PRAN can do placebo in 2A, why didn't AVXL.
 Management is definitely pumping...too similar to pump for PRAN, and the Japanese drug. Same doctor said the SAME pump for PRAN.
Guys this is NO miracle drug...sorry to burst your bubble.
Its going to cost much more than what they have in the back.. Selling to Lincoln will be DILUTION.
big selloff tomorrow.
it does not compute because a penny stock most likely 99.9% does not have cure of ALZ...when huge multi billion dollar bio companies have not been able to find a better treatment.
If it was such great science why hasn't someone just bought them out at such low price ???
he took his short out.
we should be AT LEAST $500- $800 MILLION market cap. FDA obviously does not think this is a fraud.
Plus look at this -
Tencent Q3 revenue up 34 percent on strong ad income, gaming growth.
GAMING is back !! YY will see upper 60s after earnings.
NTES is gaming...and it looks like it has rebounded nicely this qtr. YY will do really well this qtr, as gaming was the only area lagging last qtr.
VIPS is selling winter clothes in warm weather...not the same comparison.
if the decide to buy it out at $68, we get some 15% premium....if they decide not to buy, stock goes up as the buyout has been holding it down. NTES just blew away earnings on games...YY will also do very well. BABA also beat earnings.
HZNP now more than ever needs to get new acquisition to make sure for lost revenue due to express script cutting them out. I bet they go aggressive now with $33 offer. Depo will take it.
he said the same about PRAN...look it up. He is not reliable.
all this could be baised...even with the dr. He said same thing about PRAN before it collapsed.
like that is going to make any difference ?? The science and results are in question, dilution is in question, so patent is not going to help...till they come out with 2B results.